Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
07/2007
07/25/2007CN1327766C Compounds, compositions, and methods for controlling biofilms
07/25/2007CN101006090A Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof
07/25/2007CN101006058A Chemical compounds I
07/25/2007CN101006057A Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor CCR5
07/25/2007CN101006042A Chemical compounds
07/25/2007CN101003534A Antibiosis compound, and application
07/25/2007CN101003507A Compound of amide chlorotrifluoro chrysanthemic acid containing piperidine, preparation and application
07/24/2007US7247756 1,4-disubstituted benzenes as insecticides
07/24/2007US7247731 Ligands for metals and improved metal-catalyzed processes based thereon
07/24/2007US7247730 dexmethylphenidate hydrochloride, with high optical purity, which excludes the use of expensive resolving agents; novel intermediates
07/24/2007US7247729 pipecolic acid or an acid salt reacted with an amine (i,e 2,6-dimethylaniline) in an inert solvent in presence of a condensing agent such as dicyclohexylcarbodiimide, 1-ethyl-2-(2-dimethylaminopropyl)carbodiimide, methanesulfonyl chloride or phosphoryl chloride to form pipecolic acid-2,6-xylidide
07/24/2007US7247725 Gamma-aminoamide modulators of chemokine receptor activity
07/24/2007US7247645 Dihydropyridine derivatives
07/23/2007CA2567016A1 A method for the preparation of dicarboxylic imides
07/19/2007WO2007081690A2 Inhibitors of protein kinases
07/19/2007WO2007081335A1 Therapeutic compounds for treating dyslipidemic conditions
07/19/2007WO2007080140A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
07/19/2007WO2007059613B1 Antineoplastic compounds
07/19/2007WO2007035722A3 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
07/19/2007US20070167635 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
07/19/2007US20070167631 Novel herbicides
07/19/2007US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
07/19/2007US20070167487 Novel alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
07/19/2007US20070167486 such as 3-[1-(2,4-Dimethoxybenzyl)-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-hydroxypropionamide, used for preventing and treating the inflammatory diseases, for example rheumatoid arthritis, gout, osteoarthritis, lupus, arthritis, Crohn's disease, diabetes, bursitis, burns and scaring
07/19/2007US20070167458 Tetrahydro-naphthalene and urea derivatives
07/19/2007US20070167430 Compounds useful in therapy
07/19/2007US20070167425 Compound capable of binding s1p receptor and pharmaceutical use thereof
07/19/2007US20070167406 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
07/19/2007CA2635719A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
07/18/2007EP1807396A1 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
07/18/2007EP1807395A1 Process for the synthesis of n-alkoxyamines
07/18/2007EP1807394A1 Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines
07/18/2007EP1807393A1 Diarylsulfones as 5-ht2a antagonists
07/18/2007EP1807078A1 Diaminoalkane aspartic protease inhibitors
07/18/2007EP1807072A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
07/18/2007EP1515945A4 Method for making aryl hydrazines and substituted indoles
07/18/2007EP1180097B1 Mutual salt of amlodipine and atorvastatin
07/18/2007CN1326853C Novel 4-2-furoylaminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
07/18/2007CN101001850A Amido compounds and their use as pharmaceuticals
07/18/2007CN101001839A Method for preparing n-aminopiperidine and its salts
07/18/2007CN101001838A DPP-IV inhibitors
07/18/2007CN101001836A Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
07/18/2007CN100999525A Preparation process of clopidogre and its salt
07/17/2007US7244848 N-[4-[(1E)-3-amino-1-propenyl]phenyl]-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide; for treatment of hyperlipidemia, obesity and type II diabetes
07/17/2007US7244751 N-(2-amino-5-fluorophenyl)-4-[N-(Pyridn-3-ylacryloyl)aminomethyl]benzamide or other derivatives for treating cancer and psoriasis
07/17/2007CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
07/17/2007CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
07/17/2007CA2279960C Synthesis of terfenadine and derivatives
07/12/2007WO2007079078A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
07/12/2007WO2007079003A2 Amide inhibitors of leukotriene a4 hydrolase
07/12/2007WO2007078335A2 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
07/12/2007WO2007077861A1 NF-κB INHIBITOR
07/12/2007WO2007077508A2 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors
07/12/2007WO2007077443A1 Process and intermediate for preparation of donepezil
07/12/2007WO2007077005A1 3 , 5-substitγued piperidine compounds as renin inhibitors
07/12/2007WO2007053700A3 Use of pyridoxamine to treat and/or prevent disease processes
07/12/2007WO2007053427A3 Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
07/12/2007WO2007052310A3 Polymorphs of fexofenadine hydrochloride and process for their preparation
07/12/2007WO2007038459A3 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
07/12/2007WO2007029078A3 Succinimide and glutarimide derivatives as adrenergic receptor antagonists
07/12/2007WO2006123244A3 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
07/12/2007WO2006074957A9 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
07/12/2007WO2006063293A3 THIOUREAS AS FACTOR Xa INHIBITORS
07/12/2007US20070161678 Methods for the synthesis of pyridoxamine
07/12/2007US20070161675 Processes for hydrazine addition to acrylic macromonomers and products therefrom
07/12/2007US20070161674 Useful in causing mitotic arrest and cell death; (cis,trans)-1-cyclopentyl-4-phenyl-5-(phenylcarbonyl)(3-piperidyl)phenyl ketone
07/12/2007US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5)
07/12/2007US20070161643 Pyridin-2-one compounds useful as inhibitors of thrombin
07/12/2007US20070161641 2-(4-thieno[2,3-d]isoxazol-3-yl-piperidin-1-ylmethyl)-(2R,3R)-cyclopropanecarboxylic acid (trans4-methyl-cyclohexyl)-amide; psychological disorders, neurodegenerative diseases, antidepressant; drug abuse, sleep disorders
07/12/2007US20070161622 Diamino alcohols and their use as renin inhibitor
07/12/2007US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists
07/12/2007US20070160625 Prepared by extracting fungi Marasmius androsaceus L.es Fr with an organic solvent, an aqueous organic solvent or water, and concentrating the obtained extractive; use in treatment of cardiovascular disorders
07/12/2007US20070160537 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia
07/12/2007DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases
07/12/2007CA2636929A1 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
07/12/2007CA2635550A1 Process and intermediate for preparation of donepezil
07/12/2007CA2633624A1 3,5-substituted piperidine compounds as renin inhibitors
07/11/2007EP1806341A2 (+)Phenyl-(4-{4-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-phenyl}-piperidin-1-yl)-acetic acid methyl ester as lipid lowering agent
07/11/2007EP1806121A1 Anti-graying preparation
07/11/2007EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
07/11/2007EP1805152A2 Insecticidal 3-(dihaloalkenyl) phenyl derivatives
07/11/2007EP1805141A1 Piperidines and related compounds for treatment of alzheimer's disease
07/11/2007EP1805132A2 Novel compounds
07/11/2007EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof
07/11/2007CN1997641A Diarylamine derivatives as calcium channel blockers
07/11/2007CN1997631A New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
07/11/2007CN1997630A New disubstituted phenylpiperidines as modulators of dopamine neurotransmission
07/11/2007CN1997628A Thio-substituted biaryl-methanesulfinyl derivatives
07/11/2007CN1995017A Method for catalytic hydrogenation of acyl pyridine to preparing substituted pyridine compound hydrochlorate
07/11/2007CN1325473C Novel azasugar derivative and drug containing the same as the active ingredient
07/11/2007CN1325472C Phenyl-substituted cyclic enaminones
07/10/2007US7241902 for treatment of hypertension, elevated triglycerides, and elevated insulin
07/10/2007US7241811 Amide compounds for the potentiation of cholinergic activity
07/10/2007US7241810 For therapy of inflammatory, allergic and respiratory diseases
07/10/2007US7241787 Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
07/10/2007US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
07/10/2007US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
07/10/2007US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/10/2007US7241601 Bioconversion of terfenadine with a microorganism culture of Absidia corymbifera to obtain a racemic mixture of fexofenadine; specificity of the bioconversion with these microorganisms, good yield and little or no by-products
07/05/2007WO2007076104A1 Vanilloid receptor ligands and their use in treatments